Abstract:PURPOSE:To compare retrospectively the effects of percutaneous radiofrequency (RF) ablation with those of hepatic resection in the treatment of hepatocellular carcinoma (HCC) measuring 2 cm or smaller. MATERIALS AND METHODS:This study was approved by the institutional ethics committee, and all patients provided written informed consent before treatment. From December 2003 to December 2008, 145 patients with a resectable HCC measuring 2 cm or smaller were studied. Sixty-six patients had a central HCC (located at least 3 cm from the liver capsule). As an initial treatment, 71 patients were treated with percutaneous RF ablation and 74 with surgical resection. Of the patients with central HCC, 37 underwent percutaneous RF ablation and 29 underwent surgical resection. Survival curves were constructed with the Kaplan-Meier method and compared by using the log-rank test. The relative prognostic significance of the variables for predicting overall survival rates was assessed with multivariate Cox proportional hazards regression analysis. Complications were observed clinically when patients were admitted and assessed by telephone interview after patients were discharged. RESULTS:One death was considered to be related to treatment after surgical resection. Major complications occurred significantly more often in the surgical resection group (38 of 74 patients) than in the RF ablation group (14 of 71 patients) (P = .009). The 1-, 3-, and 5-year overall survival rates were 98.5%, 87.7%, and 71.9%, respectively, with RF ablation and 90.5%, 70.9%, and 62.1% with surgical resection (P = .048). The corresponding recurrence-free survival rates were 76.4%, 65.2%, and 59.8% with RF ablation and 75.6%, 56.1%, and 51.3% with surgical resection (P = .548). At subgroup analysis of patients with central HCC, 1-, 3-, and 5-year overall survival rates were 96.6%, 93.0%, and 79.9% with RF ablation and 92.0%, 71.6%, and 61.5% with surgical resection (P = .020). The corresponding recurrence-free survival rates were 86.5%, 74.0%, and 67.0% with RF ablation and 68.0%, 40.0%, and 40.0% with surgical resection (P = .033). For patients with peripheral HCC, 1-, 3-, and 5-year overall survival rates were 97.3%, 83.3%, and 65.1% with RF ablation and 87.8%, 68.4%, and 62.9% with surgical resection (P = .464). The corresponding recurrence-free survival rates were 68.7%, 59.2%, and 54.9% with RF ablation and 82.9%, 66.6%, and 52.9% with surgical resection (P = .351). CONCLUSION:The efficacy and safety of percutaneous RF ablation were better than those of surgical resection in patients with HCC measuring 2 cm or smaller, especially those with central HCC.

Tumor Size and Location Affecting the Treatment Selection for Solitary Small Recurrent Hepatocellular Carcinoma (≤3.0cm) after Initial Hepatectomy.

IDDF2019-ABS-0094 Tumor Size and Location Affecting the Treatment Selection for Solitary Small Recurrent Hepatocellular Carcinoma (≤3.0 Cm) after Initial Hepatectomy

Surgical Resection Plus Radiofrequency Ablation Versus Radical Surgery for Hepatocellular Carcinoma: A Propensity Score Matching Analysis.

The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC

Comparative Effectiveness of Radiofrequency Ablation Vs. Surgical Resection for Patients with Solitary Hepatocellular Carcinoma Smaller Than 5 Cm

Radiofrequency Ablation Versus Surgical Resection for Small Unifocal Hepatocellular Carcinomas

Comparison of Open Liver Resection and RFA for the Treatment of Solitary 3-5 Cm Hepatocellular Carcinoma: a Retrospective Study

Radiofrequency ablation versus surgical resection for the treatment of solitary hepatocellular carcinoma 2 cm or smaller: A cohort study in Taiwan

Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study.

Radiofrequency Ablation Versus Laparoscopic Hepatectomy for Hepatocellular Carcinoma: A Real World Single Center Study.

Effects of Percutaneous Radiofrequency Ablation and Repeat Hepatectomy for the Treatment of Solitary Recurrent Hepatocellular Carcinoma with the Diameter No More Than 3 Cm

A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma.

Comparison of resection, ablation and stereotactic body radiation therapy in treating solitary hepatocellular carcinoma ≤ 5 cm: a retrospective, multicenter, cohort study

Local Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma: Treatment Choice and Outcome

Tumor Location Influences Oncologic Outcomes of Hepatocellular Carcinoma Patients Undergoing Radiofrequency Ablation

Percutaneous Radiofrequency Ablation and Surgical Resection for Small Hepatocellular Carcinoma:A Comparative Study

Radiofrequency ablation is an inferior option to liver resection for solitary hepatocellular carcinoma ≤ 5 cm without cirrhosis: A population-based study with stratification by tumor size

Treatment Optimization for Recurrent Hepatocellular Carcinoma: Repeat Hepatic Resection Versus Radiofrequency Ablation

Therapeutic effect of radiofrequency ablation in unsuitable operative small hepatocellular carcinoma

Radiofrequency Ablation Versus Surgical Resection for Intrahepatic Hepatocellular Carcinoma Recurrence

Is Hepatic Resection Always a Better Choice Than Radiofrequency Ablation for Solitary Hepatocellular Carcinoma Regardless of Age and Tumor Size?